期刊文献+

^(18)F-FDG SPECT/CT诊断肺癌骨转移的价值:与全身骨显像比较 被引量:5

^(18)F-FDG SPECT/CT Detection of Bone Metastases from Lung Cancer:Comparison of ^(99)Tc^m-MDP Whole-body Bone Scan
下载PDF
导出
摘要 目的:探讨^(18)F-FDG SPECT/CT肿瘤代谢显像在诊断肺癌骨转移方面的应用价值。材料和方法:对32例肺癌患者分别进行^(18)F-FDG SPECT/CT显像和^(99)Tc^m-MDP全身骨显像,间隔时间不超过2周。其他影像学和临床随访结果为确诊依据,比较两种方法诊断骨转移的敏感性、特异性、阳性预测值、阴性预测值和准确性。结果:11个病人共48个病灶最终诊断为骨转移。^(18)F-FDG SPECT/CT诊断11个病人有骨转移,^(99)Tc^m- MDP全身骨显像诊断10个病人。按病灶分析,FDG和MDP的敏感性、特异性、阳性预测值、阴性预测值、准确性分别为94%、71%、89%、92%、77%和83%、64%、79%、89%、53%。^(18)F-FDG SPECT/CT的敏感性和准确性优于^(99)Tc^m-MDP全身骨显像(P<0.05)。结论:^(18)F-FDG SPECT/CT显像在诊断肺癌骨转移方面的敏感性和准确性高于^(99)Tc^m-MDP全身骨显像。 Purpose: To compare the sensitivity, specificity and accuracy of ^18F- FDG SPECT/CT coin- cident imaging and ^99Tc^m - MDP whole -body bone scan(WBS) for detecting bone metastases from lung cancer. Materials and Methods: ^18F- FDG SPECT/CT and ^99Tc^m - MDP WBS were performed on 32 patients, who were confirmed with lung cancer by histological exam and distant metastases were suspected. The interval of both examinations was within 2 weeks. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were calculated for SPECT/ CT and WBS. The chi - square test was utilized to compare these values. Results: Eleven patients with 48 bone loci were diagnosed as ma- lignant involvement. The sensitivity, specificity, accuracy, positive and negative predictive values of ^18F- FDG SPECT/CT were 94%, 71%, 89%, 92%, 77%, respectively. The sensitivity, specificity, and positive and negative predictive values of ^99Tc^m - MDP WBS were 83%, 64%, 79%, 89%, 53%, respectively. ^18F- FDG SPECT/CT is more sensitive and accurate than ^99Tc^m - MDP WBS and the difference had statistical significant(P 〈 0.05) . Conclusion: This study suggests that ^18F- FDG SPECT/ CT is more sensitive and accurate than ^99Tc^m - MDP WBS in detecting bone metastases from lung cancer.
出处 《中国医学计算机成像杂志》 CSCD 2007年第3期213-216,共4页 Chinese Computed Medical Imaging
关键词 ^18F—FDG ^99Tc^m—MDP SPECT/CT 肺癌 骨转移 ^18F- FDG ^99Tc^m - MDP SPECT/CT Lung cancer Bone metastases
  • 相关文献

参考文献7

  • 1Rohren EM,Turkington TG,Coleman RE.Clinical applications of PET in oncology.Radiology,2004,231:305-332.
  • 2Lardinois D,Weder W,Hany TF,et al.Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.N Engl J Med,2003,348:2500-2507.
  • 3Cheran SK,Herndon JE,Patz EF.Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.Lung Cancer,2004,44:317-325.
  • 4Maroun K,Tariq R,Jeffrey C,et al.FDG PET scan and TC 99m MDP bone scan are complementary modalities for the evaluation and follow-up of lung and breast cancer metastatic to bone.Anal Nucl Med,2005,46:33 (abstract).
  • 5Kato H,Miyazaki T,Nakajima M,et al.Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.Anticancer Res,2005,25:4439-4444.
  • 6Fogelman I,Cook G,Israel O,et al.Positron emission tomography and bone metastases.Semin Nucl Med,2005,35:135-142.
  • 7Even-Sapir E.Imaging of malignant bone involvement by morphologic,scintigraphic,and hybrid modalities.J Nucl Med,2005,46:1356-1367.

同被引文献49

  • 1孙达.放射性核素显像[M].杭州:浙江大学出版社,2000.310~313.
  • 2刘兴党,张光明,蒯大禹,林祥通,陈绍亮,李蓓蕾,李林法,朱阳军,刘增礼,唐军,莫逸,易济民,石峰,贺佳,马修强.^(89)SrCl_2注射液治疗肿瘤骨转移致骨痛的多中心临床研究(Ⅱ)[J].中华核医学杂志,2007,27(4):245-247. 被引量:6
  • 3Saba N, Khuri F. The role of bisphosphonates in the managemeng of advanced cancer with a focus on non-small-cell lung cancer. Part 1 Mechanisms of action,role of biomarkers and predinical applications [J]. Oncology ,2005,68"( 1 ) : 10-17.
  • 4Ktsalicky J, Nrajska V. The effect of repeated stronyium-89 chloricle therapy on bone pain palliation inpatients with skeletal cancer me- tastase[ J]. Eur J Nucl Med, 1998,25 : 1363-1367.
  • 5李少林,王荣福.核医学[M].第7版.北京:人民卫生出版社,2008:152-164.
  • 6Utsunomiya D, Shiraishi S, Imuta M, et al. Added Value of SPECT/CT Fusion in Assessing Suspected Bone Metastasis: Com- parison with Scintigraphy Alone and Nonfused Scintigraphy and CT [ J ]. Radiology, 2006, 238:264-271.
  • 7i Robinson R G, Preston D F, Schiefellbein M, et al. Strentium-89 therapy for the pslliation of pain due to osseous metastases [ J ]. JAMA, 1995,274:420424.
  • 8Laing A H, Ackery D M, Bayly R J, et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy [ J ]. British J Ra- diology, 1991,64:816-812.
  • 9Blake G M, Zivanovic M A, McEwan A J, et al. Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate [ J ]. Eur J Nuel Med,1986,12:447..454.
  • 10Crawford E D,Balmer C,Kozlowski J M,el al. The use of strontium 89 for palliation of pain from bone metastases associated with hor- mone refractory prostate cancer[ J]. Urology, 1994,44:481-485.

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部